NASDAQ:ATOS

Atossa Therapeutics, Inc Earning Date

USA |NASDAQ |USD

ATOS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 11, 2021 Sep 2021 $-0.04 $-0.06 $-0.34
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 11, 2021 Sep 2021 $0.00 $0.00 $0.00

Atossa Therapeutics, Inc's next earnings date is Thursday, Nov 11, 2021 for the fiscal quarter ending Sep 2021.

ATOS Earnings Date & History Chart

ATOS Earnings & Revenue Forecast

ATOS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.04 $-0.06 $-0.03
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.17 $-0.21 $-0.14
Dec 2022 2 $-0.18 $-0.22 $-0.15

ATOS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.04 $-0.03 $-0.03
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.17 $-0.14 $-0.14
Dec 2022 0 / 0 $-0.18 $-0.15 $-0.15

ATOS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $0.00 $0.00 $0.00
Dec 2022 2 $0.00 $0.00 $0.00

ATOS Earnings Date & Revenue History

ATOS Earnings History

|
Show More
Show More

ATOS Revenue History

|
Show More
Show More

Atossa Therapeutics, Inc Next Earnings Date & Report

ATOS Next Earnings Date & Report Preview: Sep 2021 (FQ)

ATOS's next earnings date is Thursday, Nov 11, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 2 analysts, the average EPS estimation for Atossa Therapeutics, Inc's next quarterly earnings is $-0.04, with a low EPS estimation of $-0.06, and a high estimation of $-0.03.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.04, the last 2 month trend is $-0.03, and the 3 month trend is $-0.03.

Based on 2 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Atossa Therapeutics, Inc Previous Earnings Dates & Reports

ATOS Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Atossa Therapeutics, Inc's previous earnings date was Aug 13, 2021 for its fiscal quarter ended Jun 30, 2021.

ATOS's earnings per share (EPS) was $-0.06, missing the consensus analysts forecast of $-0.04 by -71.43%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 50.00%, and higher than the same period a year before (Jun 2020) by -86.05%.

Revenues were $0.00.

The company reported a net income of $-7.04M.

Free cash flow for the quarter was $-5.34M , compared to $-4.41M last quarter and $-2.24M a year before.

ATOS ended the quarter with $4.72K in total debt, a decrease of -41.10% compared to the previous quarter, and a decrease of -89.33% compared to the same quarter a year before.

ATOS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Atossa Therapeutics, Inc's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

ATOS's earnings per share (EPS) was $-1.97, missing the consensus analysts forecast of $-1.20 by 64.17% , and higher than the previous year's EPS (Dec 2019) by -3.43%.

Revenues were $0.00.

The company reported a net income of $-17.83M.

Atossa Therapeutics, Inc reported a free cash flow of $-11.57M for its fiscal year, compared to $-9.14M a year ago.